B. Metzler seel. Sohn & Co. Holding AG Invests $9.98 Million in Intuitive Surgical, Inc. (NASDAQ:ISRG)

B. Metzler seel. Sohn & Co. Holding AG bought a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 20,309 shares of the medical equipment provider's stock, valued at approximately $9,977,000.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Mirador Capital Partners LP lifted its stake in shares of Intuitive Surgical by 1.4% in the 3rd quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider's stock valued at $1,732,000 after purchasing an additional 50 shares during the period. Advisors Asset Management Inc. lifted its holdings in shares of Intuitive Surgical by 18.1% during the first quarter. Advisors Asset Management Inc. now owns 7,380 shares of the medical equipment provider's stock valued at $2,945,000 after purchasing an additional 1,129 shares during the last quarter. Consolidated Planning Corp grew its stake in shares of Intuitive Surgical by 17.4% in the 3rd quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider's stock worth $3,979,000 after buying an additional 1,198 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund increased its position in Intuitive Surgical by 617.1% during the 2nd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 89,069 shares of the medical equipment provider's stock valued at $39,622,000 after buying an additional 76,649 shares in the last quarter. Finally, ABLE Financial Group LLC bought a new position in Intuitive Surgical during the 3rd quarter valued at approximately $604,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Price Performance

Intuitive Surgical stock traded up $3.00 during midday trading on Wednesday, hitting $541.82. 984,907 shares of the company were exchanged, compared to its average volume of 1,456,895. Intuitive Surgical, Inc. has a fifty-two week low of $304.50 and a fifty-two week high of $544.38. The company's fifty day moving average price is $502.44 and its 200-day moving average price is $461.26. The company has a market cap of $192.98 billion, a PE ratio of 87.11, a price-to-earnings-growth ratio of 5.19 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The company had revenue of $2.04 billion during the quarter, compared to analysts' expectations of $2.01 billion. On average, analysts expect that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Insider Buying and Selling

In other Intuitive Surgical news, SVP Henry L. Charlton sold 40,243 shares of the business's stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $486.84, for a total value of $19,591,902.12. Following the completion of the transaction, the senior vice president now directly owns 3,001 shares of the company's stock, valued at approximately $1,461,006.84. The trade was a 93.06 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Robert Desantis sold 188 shares of the company's stock in a transaction that occurred on Thursday, August 29th. The shares were sold at an average price of $482.21, for a total value of $90,655.48. Following the completion of the sale, the executive vice president now owns 5,506 shares in the company, valued at $2,655,048.26. This represents a 3.30 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 91,178 shares of company stock valued at $45,897,071. Corporate insiders own 0.80% of the company's stock.

Analysts Set New Price Targets

A number of research firms recently weighed in on ISRG. The Goldman Sachs Group set a $604.00 price objective on Intuitive Surgical in a research report on Friday, October 18th. Truist Financial raised their price objective on Intuitive Surgical from $520.00 to $570.00 and gave the company a "buy" rating in a research report on Monday, October 14th. Erste Group Bank raised Intuitive Surgical from a "hold" rating to a "buy" rating in a report on Tuesday. Citigroup lifted their target price on Intuitive Surgical from $512.00 to $560.00 and gave the stock a "buy" rating in a report on Thursday, August 22nd. Finally, Stifel Nicolaus upped their target price on shares of Intuitive Surgical from $475.00 to $525.00 and gave the stock a "buy" rating in a research report on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have given a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $524.61.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.